Stay updated on IPI-145 Plus FCR in CLL Clinical Trial

Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A newer revision label (v3.5.4) has been added, replacing the previous v3.5.3. This reflects a minor release update to the page's documentation rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-05-15T15:35:10.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page’s footer “Revision” has been updated from v3.5.2 to v3.5.3, indicating a new website release version without changing the displayed study details.
    Difference
    0.1%
    Check dated 2026-04-24T05:25:14.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:03.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added the term 'B-cell chronic lymphocytic leukemia' and a 'Genetic and Rare Diseases Information Center' resource to the study page.
    Difference
    0.2%
    Check dated 2026-04-02T14:58:16.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible content or feature changes are indicated.
    Difference
    0.1%
    Check dated 2026-03-18T20:57:44.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The page revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:37:39.000Z thumbnail image

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.